Page 127 - 《中国药房》2022年15期

dihydroartemisinin-piperaquine for the treatment of un- tol，2017，33（3）：242-253.
complicated falciparum malaria in Kibaha and Kigoma， [34] RAMHARTER M. Artemisinin-based combination thera-
Tanzania[J]. Malar J，2019，18（1）：99. py for knowlesi malaria[J]. Lancet Infect Dis，2016，16
[23] SOWUNMI A，AKANO K，NTADOM G，et al. Therapeu- （2）：134-136.
tic efficacy and effects of artemisinin-based combination [35] SHIBESHI W，ALEMKERE G，MULU A，et al. Efficacy
treatments on uncomplicated Plasmodium falciparum ma- and safety of artemisinin-based combination therapies for
laria-associated anaemia in Nigerian children during se- the treatment of uncomplicated malaria in pediatrics：a sys-
ven years of adoption as first-line treatments[J]. Infect Dis tematic review and meta-analysis[J]. BMC Infect Dis，
Poverty，2017，6（1）：36. 2021，21（1）：326.
[24] RUSSOM M，TESFAI D，GEBREGIORGIS S，et al. Arte- [36] ROGERSON S J. Management of malaria in pregnancy
sunate/amodiaquine-induced acute extrapyramidal reac- [J]. Indian J Med Res，2017，146（3）：328-333.
tions in children and younger adults：case series assess- [37] WHO Malaria Policy Advisory Committee and Secretariat.
ment[J]. Drug Saf，2016，39（8）：763-768. Malaria Policy Advisory Committee to the WHO：conclu-
[25] KEATING G M. Dihydroartemisinin/piperaquine：a re- sions and recommendations of eighth biannual meeting
view of its use in the treatment of uncomplicated Plasmo- （September 2015）[J]. Malar J，2016，15：117.
dium falciparum malaria[J]. Drugs，2012，72（7）：937-961. [38] AUGUSTO O，STERGACHIS A，DELLICOUR S，et al.
[26] ASSEFA D G，ZELEKE E D，BEKELE D，et al. Efficacy First trimester use of artemisinin-based combination thera-
and safety of dihydroartemisinin-piperaquine versus arte- py and the risk of low birth weight and small for gestational
mether-lumefantrine for treatment of uncomplicated Plas- age[J]. Malar J，2020，19（1）：144.
modium falciparum malaria in Ugandan children：a sys- [39] NAMBOZI M，KABUYA J B B，HACHIZOVU S，et al.
tematic review and meta-analysis of randomized control Artemisinin-based combination therapy in pregnant women
trials[J]. Malar J，2021，20（1）：174. in Zambia：efficacy，safety and risk of recurrent malaria
[27] HAN K T，LIN K，MYINT M K，et al. Artemether-lume- [J]. Malar J，2017，16（1）：199.
fantrine and dihydroartemisinin-piperaquine retain high ef- [40] Pregact Study Group，PEKYI D，AMPROMFI A A，et al.
ficacy for treatment of uncomplicated Plasmodium falci- Four artemisinin-based treatments in African pregnant
parum malaria in Myanmar[J]. Am J Trop Med Hyg， women with malaria[J]. N Engl J Med，2016，374（10）：
2020，102（3）：598-604. 913-927.
[28] KADIA B M，MORFAW C，SIMO A C G. Choreoatheto- [41] NAMBOZI M，TINTO H，MWAPASA V，et al. Artemi-
sis：an unusual adverse effect of dihydroartemisinin-pipera- sinin-based combination therapy during pregnancy：out-
quine：a case report[J]. J Med Case Rep，2017，11（1）：360. come of pregnancy and infant mortality：a cohort study[J].
[29] GRANDESSO F，GUINDO O，WOI MESSE L，et al. Effi- Malar J，2019，18（1）：105.
cacy of artesunate-amodiaquine，dihydroartemisinin-pipera- [42] WHITE N J. Triple artemisinin-containing combination
quine and artemether-lumefantrine for the treatment of anti-malarial treatments should be implemented now to de-
uncomplicated Plasmodium falciparum malaria in Maradi， lay the emergence of resistance[J]. Malar J，2019，18（1）：
Niger[J]. Malar J，2018，17（1）：52. 338.
[30] BÉLARD S，RAMHARTER M，KURTH F. Paediatric for- [43] SCHWARTZ E，LACHISH T. Artemisinin-based combina-
mulations of artemisinin-based combination therapies for tion therapy（ACT）versus atovaquone-proguanil：do not
treating uncomplicated malaria in children[J]. Cochrane choose between but，rather，combine them[J]. Evid Based
Database Syst Rev，2020，12（12）：CD009568. Med，2016，21（2）：64.
[31] DAVLANTES E，DIMBU P R，FERREIRA C M，et al. Ef- [44] VAN DER PLUIJM R W，TRIPURA R，HOGLUND R M，
ficacy and safety of artemether-lumefantrine，artesunatea- et al. Triple artemisinin-based combination therapies ver-
modiaquine，and dihydroartemisinin-piperaquine for the sus artemisinin-based combination therapies for uncompli-
treatment of uncomplicated Plasmodium falciparum mala- cated Plasmodium falciparum malaria：a multicentre，
ria in three provinces in Angola，2017[J]. Malar J，2018， open-label，randomised clinical trial[J]. Lancet，2020，395
17（1）：144. （10233）：1345-1360.
[32] KAKAR Q，SHEIKH S，AHMED I，et al. Efficacy of arte- [45] DINI S，ZALOUMIS S，CAO P X，et al. Investigating the
misinin-based combination therapies for the treatment of efficacy of triple artemisinin-based combination therapies
falciparum malaria in Pakistan（2007-2015）：in vivo re- for treating Plasmodium falciparum malaria patients using
sponse and dhfr and dhps mutations[J]. Acta Trop，2016， mathematical modeling[J]. Antimicrob Agents Chemother，
164：17-22. 2018，62（11）：e01068-e01018.
[33] BARBER B E，GRIGG M J，WILLIAM T，et al. The treat- [46] AGARWAL D，SINGH S，GUPTA R D，et al. In vitro syner-
ment of Plasmodium knowlesi malaria[J]. Trends Parasi- gistic interaction of potent 4-aminoquinolines in combina-

中国药房 2022年第33卷第15期 China Pharmacy 2022 Vol. 33 No. 15 ·1909 ·